Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polycystic kidney disease
Carsten Bergmann, Lisa M. Guay‐Woodford, Peter C. Harris, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 592

Showing 1-25 of 592 citing articles:

Chronic Kidney Disease Diagnosis and Management
Teresa K. Chen, Daphne H. Knicely, Morgan E. Grams
JAMA (2019) Vol. 322, Iss. 13, pp. 1294-1294
Open Access | Times Cited: 1273
Targeting integrin pathways: mechanisms and advances in therapy
Xiaocong Pang, Xu He, Zhiwei Qiu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 442
The Hippo signalling pathway and its implications in human health and diseases
Minyang Fu, Yuan Hu, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 310
WNT–β-catenin signalling — a versatile player in kidney injury and repair
Stefan Schunk, Jürgen Floege, Danilo Fliser, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 3, pp. 172-184
Closed Access | Times Cited: 297
TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases
Miao Zhang, Yueming Ma, Xianglu Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 185
Inflammation and Premature Ageing in Chronic Kidney Disease
Thomas Ebert, Sven‐Christian Pawelzik, Anna Witasp, et al.
Toxins (2020) Vol. 12, Iss. 4, pp. 227-227
Open Access | Times Cited: 179
Ciliopathies and the Kidney: A Review
Dominique J. Mcconnachie, Jennifer L. Stow, Andrew Mallett
American Journal of Kidney Diseases (2020) Vol. 77, Iss. 3, pp. 410-419
Open Access | Times Cited: 167
Chronic Kidney Disease
Cornelia Charles, Allison Ferris
Primary Care Clinics in Office Practice (2020) Vol. 47, Iss. 4, pp. 585-595
Closed Access | Times Cited: 165
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney
Hülya Bayır, Scott J. Dixon, Yulia Y. Tyurina, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 5, pp. 315-336
Closed Access | Times Cited: 156
Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice
Nine V.A.M. Knoers, Corinne Antignac, Carsten Bergmann, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. 2, pp. 239-254
Open Access | Times Cited: 113
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype
Sarah R. Senum, Ying Li, Katherine A. Benson, et al.
The American Journal of Human Genetics (2021) Vol. 109, Iss. 1, pp. 136-156
Open Access | Times Cited: 103
A scalable organoid model of human autosomal dominant polycystic kidney disease for disease mechanism and drug discovery
Tracy Tran, Cheng Song, Trang Nguyen, et al.
Cell stem cell (2022) Vol. 29, Iss. 7, pp. 1083-1101.e7
Open Access | Times Cited: 79
Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery
Ken Hiratsuka, Tomoya Miyoshi, Katharina T. Kroll, et al.
Science Advances (2022) Vol. 8, Iss. 38
Open Access | Times Cited: 77
Role of necroptosis in kidney health and disease
Benedikt Kolbrink, Friedrich Alexander von Samson‐Himmelstjerna, James M. Murphy, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 5, pp. 300-314
Closed Access | Times Cited: 41
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Vicente E. Torres, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. 234-254
Open Access | Times Cited: 5
KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Olivier Devuyst, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. S1-S239
Open Access | Times Cited: 4
Intracranial Aneurysms: Pathology, Genetics, and Molecular Mechanisms
Zhen Xu, Yan‐Ning Rui, John P. Hagan, et al.
NeuroMolecular Medicine (2019) Vol. 21, Iss. 4, pp. 325-343
Open Access | Times Cited: 102
Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease
Yi Lu, Yongzhan Sun, Zhiheng Liu, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 554
Closed Access | Times Cited: 86
Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players
Andrea Domingo-Gallego, Marc Pybus, Gemma Bullich, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. 4, pp. 687-696
Closed Access | Times Cited: 77
Refining genotype–phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants
Kathrin Burgmaier, Leonie Violetta Brinker, Florian Erger, et al.
Kidney International (2021) Vol. 100, Iss. 3, pp. 650-659
Open Access | Times Cited: 65
Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease
Alex R. Chang, Bryn S. Moore, Jonathan Z. Luo, et al.
JAMA (2022) Vol. 328, Iss. 24, pp. 2412-2412
Open Access | Times Cited: 52
Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis
Hugo Lemoine, Loann Raud, François Foulquier, et al.
The American Journal of Human Genetics (2022) Vol. 109, Iss. 8, pp. 1484-1499
Open Access | Times Cited: 45
Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment
Jana Reiterová, Vladimı́r Tesař
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3317-3317
Open Access | Times Cited: 39
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial
Sadrija Cukoski, Christoph Heinrich Lindemann, Sita Arjune, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101283-101283
Open Access | Times Cited: 36
A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases
Francesca Becherucci, Samuela Landini, Viviana Palazzo, et al.
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 4, pp. 706-720
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top